SEC Filing Summary: Babcock & Wilcox Enterprises, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Babcock & Wilcox Enterprises, Inc. on November 27, 2018. The report addresses a regulatory notice received from NYSE Regulation, Inc. regarding the Company's compliance with continued listing standards on the New York Stock Exchange (NYSE).
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The only financial metric disclosed is the Company's stock price performance, which triggered the regulatory notice.
Material Changes and Events
- Listing Non-Compliance: The Company received notice of non-compliance with NYSE Section 802.01C due to its common stock's average closing price being less than $1.00 per share over 30 consecutive trading days.
- Trading Status: The stock will continue to trade under the symbol "BW" but will carry a ".BC" indicator to signify non-compliance with listing standards.
Outlook, Management Commentary, and Risks
- Cure Period: The Company has a six-month period from the date of the notice to regain compliance.
- Compliance Requirements: To cure the deficiency, the Company must achieve a closing share price of at least $1.00 and an average closing share price of at least $1.00 over a 30-trading-day period ending on the last trading day of any calendar month within the cure period.
- Management Action: The Company intends to submit a response to the NYSE within 10 business days stating its intent to cure the deficiency.
Investor Verification Checklist
- Verify the current trading price and 30-day average of the "BW" stock to assess progress toward the $1.00 threshold.
- Monitor the NYSE website for the ".BC" trading indicator status.
- Review subsequent filings for the Company's formal response plan submitted within the 10-business-day window.
- Check for any additional financial disclosures in quarterly reports (10-Q) or annual reports (10-K) that may explain the underlying causes of the stock price decline.